Financial Times letter<\/a> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3474", "label" : {"_value" : "Biography information for Baroness Anelay of St Johns"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Anelay of St Johns"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/748011/answer/attachment/1", "fileName" : {"_value" : "Hunt & Clark FT letter .pdf"}
, "title" : "Hunt and Clark FT letter"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T13:01:18.157Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "203"}
, "answeringDeptShortName" : {"_value" : "Exiting the European Union"}
, "answeringDeptSortName" : {"_value" : "Exiting the European Union"}
, "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government whether they intend that London-based EU agencies should remain located within the UK following Brexit.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1796", "label" : {"_value" : "Biography information for Lord Taylor of Warwick"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Taylor of Warwick"}
], "uin" : "HL465"}
, {"_about" : "http://data.parliament.uk/resources/748019", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/748019/answer", "answerText" : {"_value" : "Emergency medical technicians and paramedics operate to the Joint Royal Colleges Ambulance Liaison Committee Clinical Practise Guidelines 2016. This does not refer to the use of Diphoterine. Ambulance personnel would follow the chemical, biological, radiological and nuclear advice in the guidelines to disrobe the patient and decontaminate with water.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "HL475"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T15:01:51.84Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government how they ensure that, in responding to acid attacks, first responders are adequately equipped to deal with (1) the immediate effects, and (2) the need to prevent prolonged physical damage.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1827", "label" : {"_value" : "Biography information for Baroness Uddin"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Uddin"}
], "uin" : "HL473"}
, {"_about" : "http://data.parliament.uk/resources/748020", "AnsweringBody" : [{"_value" : "Home Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/748020/answer", "answerText" : {"_value" : "
We are working closely with the National Police Chiefs\u2019 Council lead on the scale and nature of attacks with acid and other corrosive substances and how to respond to such attacks.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4311", "label" : {"_value" : "Biography information for Baroness Williams of Trafford"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Williams of Trafford"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T12:59:47.573Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "1"}
, "answeringDeptShortName" : {"_value" : "Home Office"}
, "answeringDeptSortName" : {"_value" : "Home Office"}
, "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government what action they are taking to put in place a protocol with police, local authorities, and other emergency services, to respond to acid attacks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1827", "label" : {"_value" : "Biography information for Baroness Uddin"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Uddin"}
], "uin" : "HL474"}
, {"_about" : "http://data.parliament.uk/resources/748021", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/748021/answer", "answerText" : {"_value" : "
Emergency medical technicians and paramedics operate to the Joint Royal Colleges Ambulance Liaison Committee Clinical Practise Guidelines 2016. This does not refer to the use of Diphoterine. Ambulance personnel would follow the chemical, biological, radiological and nuclear advice in the guidelines to disrobe the patient and decontaminate with water.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "HL473"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T15:01:51.937Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government whether NHS protocols for the management of acid attacks include the use of Diphotrine for the purposes of emergency treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1827", "label" : {"_value" : "Biography information for Baroness Uddin"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Uddin"}
], "uin" : "HL475"}
, {"_about" : "http://data.parliament.uk/resources/747416", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/747416/answer", "answerText" : {"_value" : "
In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.<\/p>
<\/p>
The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review\u2019s recommendations and will respond in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL381"}
, {"_value" : "HL383"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T13:59:51.17Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-03", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government when they will publish their response to the Accelerated Access Review of innovative medicines and medical technologies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/123", "label" : {"_value" : "Biography information for Lord Lansley"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Lansley"}
], "uin" : "HL380"}
, {"_about" : "http://data.parliament.uk/resources/747417", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/747417/answer", "answerText" : {"_value" : "
In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.<\/p>
<\/p>
The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review\u2019s recommendations and will respond in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL380"}
, {"_value" : "HL383"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T13:59:51.28Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-03", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government whether they intend to establish the Accelerated Access Partnership as recommended in their Accelerated Access Review; and if so when.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/123", "label" : {"_value" : "Biography information for Lord Lansley"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Lansley"}
], "uin" : "HL381"}
, {"_about" : "http://data.parliament.uk/resources/747418", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/747418/answer", "answerText" : {"_value" : "
Consistent with recommendations set out in the Accelerated Access Review, NHS England continues to develop its commercial capacity and capability in relation to medicines procurement as well as the negotiation of bespoke commercial access arrangements for high cost drugs. As part of this, the Commercial Medicines Unit transferred across from the Department to NHS England on 1 April 2017. NHS England is currently in the process of recruiting to a number of other key posts to support the commercial function more broadly.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T14:30:38.917Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-03", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government whether a strategic commercial unit will be established within NHS England, as recommended in the Accelerated Access Review, and if so, when.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/123", "label" : {"_value" : "Biography information for Lord Lansley"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Lansley"}
], "uin" : "HL382"}
, {"_about" : "http://data.parliament.uk/resources/747419", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/747419/answer", "answerText" : {"_value" : "
In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.<\/p>
<\/p>
The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review\u2019s recommendations and will respond in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL380"}
, {"_value" : "HL381"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T13:59:51.357Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-07-03", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government what plans they have to introduce a \"transformative designation\", as proposed in the Accelerated Access Review, for the most strategically important products for the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/123", "label" : {"_value" : "Biography information for Lord Lansley"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Lansley"}
], "uin" : "HL383"}
, {"_about" : "http://data.parliament.uk/resources/746635", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/746635/answer", "answerText" : {"_value" : "
\u200bOur Ambassador to Tel Aviv and our Consul-General to Jerusalem have raised our concerns with the Israeli authorities and the Palestinian Authority respectively over the situation in Gaza. The Minister for the Middle East raised the situation in Gaza with the Israeli Deputy Foreign Minister and the Israeli Ambassador to London on 22 and 23 June respectively.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"}
, "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-07-11T14:21:28.13Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "16"}
, "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"}
, "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"}
, "date" : {"_value" : "2017-06-29", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "Her Majesty's Government what representations they have made to (1) the Palestinian Authority, and (2) the government of Israel, following the reduction of electricity supply to Gaza to just 2.5 hours per day.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/200", "label" : {"_value" : "Biography information for Baroness Tonge"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Tonge"}
], "uin" : "HL266"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&houseId=2&answer.dateOfAnswer=2017-07-11&max-answer.questionFirstAnswered.=2017-07-11T15%3A02%3A39.453Z", "page" : 0, "startIndex" : 1, "totalResults" : 33, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}